313 related articles for article (PubMed ID: 16143222)
1. Gynecologists' attitudes towards hormone therapy in the post "Women's Health Initiative" study era.
Nassar AH; Abd Essamad HM; Awwad JT; Khoury NG; Usta IM
Maturitas; 2005 Sep; 52(1):18-25. PubMed ID: 16143222
[TBL] [Abstract][Full Text] [Related]
2. Attitudes of Korean clinicians to postmenopausal hormone therapy after the Women's Health Initiative study.
Kang BM; Kim MR; Park HM; Yoon BK; Lee BS; Chung HW; Cho SH; Choi H; Kim JG
Menopause; 2006; 13(1):125-9. PubMed ID: 16607108
[TBL] [Abstract][Full Text] [Related]
3. Patients' and clinicians' attitudes after the Women's Health Initiative study.
Blümel JE; Castelo-Branco C; Chedraui PA; Binfa L; Dowlani B; Gómez MS; Sarrá S
Menopause; 2004; 11(1):57-61. PubMed ID: 14716183
[TBL] [Abstract][Full Text] [Related]
4. The attitude of gynecologists in São Paulo, Brazil 3 years after the Women's Health Initiative study.
Lazar F; Costa-Paiva L; Morais SS; Pedro AO; Pinto-Neto AM
Maturitas; 2007 Feb; 56(2):129-41. PubMed ID: 16901660
[TBL] [Abstract][Full Text] [Related]
5. A survey of obstetrician-gynecologists concerning practice patterns and attitudes toward hormone therapy.
Power ML; Zinberg S; Schulkin J
Menopause; 2006; 13(3):434-41. PubMed ID: 16735940
[TBL] [Abstract][Full Text] [Related]
6. Hormone replacement therapy in the post-Women's Health Initiative era. Report a a meeting held in Funchal, Madeira, February 24-25, 2003.
Burger H
Climacteric; 2003 May; 6 Suppl 1():11-36. PubMed ID: 12945798
[TBL] [Abstract][Full Text] [Related]
7. New evidence regarding hormone replacement therapies is urgently required transdermal postmenopausal hormone therapy differs from oral hormone therapy in risks and benefits.
Modena MG; Sismondi P; Mueck AO; Kuttenn F; Lignières Bd; Verhaeghe J; Foidart JM; Caufriez A; Genazzani AR;
Maturitas; 2005 Sep; 52(1):1-10. PubMed ID: 15963666
[TBL] [Abstract][Full Text] [Related]
8. Use of hormone therapy by female gynecologists and female partners of male gynecologists in Germany 8 years after the Women's Health Initiative study: results of a survey.
Buhling KJ; von Studnitz FS; Jantke A; Eulenburg C; Mueck AO
Menopause; 2012 Oct; 19(10):1088-91. PubMed ID: 22692331
[TBL] [Abstract][Full Text] [Related]
9. Hormone therapy following the Women's Health Initiative (WHI) study: perception of gynecologists in Brazil.
Machado RB; Fernandes CE; Maia E; Melo NR; Baracat EC
Minerva Ginecol; 2005 Oct; 57(5):563-8. PubMed ID: 16205602
[TBL] [Abstract][Full Text] [Related]
10. Evolving practice patterns and attitudes toward hormone therapy of obstetrician-gynecologists.
Power ML; Schulkin J; Rossouw JE
Menopause; 2007; 14(1):20-8. PubMed ID: 17019376
[TBL] [Abstract][Full Text] [Related]
11. The impact of the Women's Health Initiative on hormone replacement therapy in a Medicaid program.
Hillman JJ; Zuckerman IH; Lee E
J Womens Health (Larchmt); 2004 Nov; 13(9):986-92. PubMed ID: 15665655
[TBL] [Abstract][Full Text] [Related]
12. Factors associated with obstetrician-gynecologists' response to the Women's Health Initiative trial of combined hormone therapy.
Power ML; Baron J; Schulkin J
Med Decis Making; 2008; 28(3):411-8. PubMed ID: 18480040
[TBL] [Abstract][Full Text] [Related]
13. The effect of medroxyprogesterone acetate on estrogen-dependent risks and benefits--an attempt to interpret the Women's Health Initiative results.
Kuhl H; Stevenson J
Gynecol Endocrinol; 2006 Jun; 22(6):303-17. PubMed ID: 16785155
[TBL] [Abstract][Full Text] [Related]
14. Attitudes and practices about postmenopausal hormone therapy among female gynecologists in Brazil.
Filho AS; Soares Júnior JM; Arkader J; Maciel GA; Baracat EC
Maturitas; 2005 Jun; 51(2):146-53. PubMed ID: 15917155
[TBL] [Abstract][Full Text] [Related]
15. Impacts on clinical decision making - changing hormone therapy management after the WHI.
Sturmberg JP; Pond DC
Aust Fam Physician; 2009 Apr; 38(4):249-51, 253-5. PubMed ID: 19350076
[TBL] [Abstract][Full Text] [Related]
16. Brief report: attitudes toward hormone therapy after the Women's Health Initiative: a comparison of internists and gynecologists.
Brett AS; Carney PI; McKeown RE
J Gen Intern Med; 2005 May; 20(5):416-8. PubMed ID: 15963163
[TBL] [Abstract][Full Text] [Related]
17. The effect of tibolone and continuous combined conjugated equine oestrogens plus medroxyprogesterone acetate on progression of carotid intima-media thickness: the Osteoporosis Prevention and Arterial effects of tiboLone (OPAL) study.
Bots ML; Evans GW; Riley W; McBride KH; Paskett ED; Helmond FA; Grobbee DE;
Eur Heart J; 2006 Mar; 27(6):746-55. PubMed ID: 16415304
[TBL] [Abstract][Full Text] [Related]
18. Hormone therapy prescription among physicians in France and Quebec.
Ringa V; Légaré F; Dodin S; Norton J; Godin G; Bréart G
Menopause; 2004; 11(1):89-97. PubMed ID: 14716188
[TBL] [Abstract][Full Text] [Related]
19. Prior hormone therapy and breast cancer risk in the Women's Health Initiative randomized trial of estrogen plus progestin.
Anderson GL; Chlebowski RT; Rossouw JE; Rodabough RJ; McTiernan A; Margolis KL; Aggerwal A; David Curb J; Hendrix SL; Allan Hubbell F; Khandekar J; Lane DS; Lasser N; Lopez AM; Potter J; Ritenbaugh C
Maturitas; 2006 Sep; 55(2):103-15. PubMed ID: 16815651
[TBL] [Abstract][Full Text] [Related]
20. Hormone use and patient concerns after the findings of the Women's Health Initiative.
Rolnick SJ; Kopher RA; DeFor TA; Kelley ME
Menopause; 2005; 12(4):399-404. PubMed ID: 16037754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
